Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PSMA-targeting ligands with optimal properties for imaging and therapy

PSMA-targeting ligands with optimal properties for imaging and therapy

US Patent 12156921 · Granted Dec 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PSMA-targeting ligands with optimal properties for imaging and therapy2025
PSMA-targeting ligands with optimal properties for imaging and therapy2025
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Cationic cyclic amine and amphipathic transfection reagents2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunot2023
Long-lived gadolinium based tumor targeted imaging and therapy agents2023
Luminescent phospholipid analogs for the identification and isolation of circula2022
Phospholipid ether analogs as cancer-targeting drug vehicles2022
Radioactive phospholipid metal chelates for cancer imaging and therapy2021
Radioactive phospholipid metal chelates for cancer imaging and therapy2021
Long-lived gadolinium based tumor targeting imaging and therapy agents2020